Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)-PLUS
Condition: Multidrug Resistant Tuberculosis Interventions: Drug: Bedaquiline; Drug: Pyrazinamide; Drug: Linezolid; Drug: Cycloserine; Drug: Clofazimine Sponsor: Huashan Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2021 Category: Research Source Type: clinical trials
Evaluating the EBA of Meropenem With Amoxicillin/Clavulanate and Pyrazinamide or Bedaquiline in Adults With PTB
Condition: Tuberculosis Interventions: Drug: Meropenem Injection; Drug: Amoxicillin Clavulanate; Drug: Pyrazinamide; Drug: Bedaquiline; Drug: Rifafour Sponsor: TASK Applied Science Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2020 Category: Research Source Type: clinical trials
A Study of Bedaquiline Administered as Part of a Treatment Regimen With Clarithromycin and Ethambutol in Adult Patients With Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD)
Condition: Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD) Interventions: Drug: Bedaquiline; Drug: Clarithromycin; Drug: Ethambutol; Drug: Rifampicin; Drug: Rifabutin Sponsor: Janssen Pharmaceutical K.K. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2020 Category: Research Source Type: clinical trials
Evaluating the EBA of Meropenem With Amoxicillin/Clavulanate and Pyrazinamide or Bedaquiline in Adults With PTB
Condition: Tuberculosis Interventions: Drug: Meropenem Injection; Drug: Amoxicillin Clavulanate; Drug: Pyrazinamide; Drug: Bedaquiline; Drug: Rifafour Sponsor: TASK Applied Science Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2020 Category: Research Source Type: clinical trials
A Study of Bedaquiline Administered as Part of a Treatment Regimen With Clarithromycin and Ethambutol in Adult Patients With Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD)
Condition: Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD) Interventions: Drug: Bedaquiline; Drug: Clarithromycin; Drug: Ethambutol; Drug: Rifampicin; Drug: Rifabutin Sponsor: Janssen Pharmaceutical K.K. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2020 Category: Research Source Type: clinical trials
Evaluating the EBA of Meropenem With Amoxicillin/Clavulanate and Pyrazinamide or Bedaquiline in Adults With PTB
Condition: Tuberculosis Interventions: Drug: Meropenem Injection; Drug: Amoxicillin Clavulanate; Drug: Pyrazinamide; Drug: Bedaquiline; Drug: Rifafour Sponsor: TASK Applied Science Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2020 Category: Research Source Type: clinical trials
A Study of Bedaquiline Administered as Part of a Treatment Regimen With Clarithromycin and Ethambutol in Adult Patients With Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD)
Condition: Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD) Interventions: Drug: Bedaquiline; Drug: Clarithromycin; Drug: Ethambutol; Drug: Rifampicin; Drug: Rifabutin Sponsor: Janssen Pharmaceutical K.K. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2020 Category: Research Source Type: clinical trials
Evaluating the EBA of Meropenem With Amoxicillin/Clavulanate and Pyrazinamide or Bedaquiline in Adults With PTB
Condition: Tuberculosis Interventions: Drug: Meropenem Injection; Drug: Amoxicillin Clavulanate; Drug: Pyrazinamide; Drug: Bedaquiline; Drug: Rifafour Sponsor: TASK Applied Science Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2020 Category: Research Source Type: clinical trials
A Study of Bedaquiline Administered as Part of a Treatment Regimen With Clarithromycin and Ethambutol in Adult Patients With Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD)
Condition: Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD) Interventions: Drug: Bedaquiline; Drug: Clarithromycin; Drug: Ethambutol; Drug: Rifampicin; Drug: Rifabutin Sponsor: Janssen Pharmaceutical K.K. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2020 Category: Research Source Type: clinical trials
